Search
T487
go.drugbank.com/drugs/DB05474ExperimentalT487 is a small molecule chemokine receptor antagonist to correct or modify immune system responses. It binds selectively and potently to CXCR3. … The formulation is administered orally and has anti-inflammatory effects in conditions such as rheumatoid arthritis, inflammatory bowel disease and psoriasis.
SCIB1
go.drugbank.com/drugs/DB18439InvestigationalSCIB1 is an investigational cancer vaccine being developed by Scancell Ltd. It is being investigated for the treatment of melanoma. … It consists of plasmid DNA molecules that express a modified antibody in human cells, working to stimulate the patient's T cells to have a stronger reaction against melanoma cells.
Talinolol
go.drugbank.com/drugs/DB11770InvestigationalTalinolol has been investigated for the basic science of Gastrointestinal Motility Disorder.
GSK-2018682
go.drugbank.com/drugs/DB11987InvestigationalGSK2018682 has been investigated for the treatment of Multiple Sclerosis, Relapsing-Remitting.
Roniciclib
go.drugbank.com/drugs/DB12974InvestigationalRoniciclib has been investigated for the treatment of Small Cell Lung Carcinoma.
APG-157
go.drugbank.com/drugs/DB18683InvestigationalNutraceuticalAPG-157 consists of zinflavonoids being investigated for the treatment of cancers.
RTX-117
go.drugbank.com/drugs/DB28443ExperimentalRTX-117 is being investigated for Charcot-Marie-Tooth disease (CMT).[L54166]
Naftopidil
go.drugbank.com/drugs/DB12092InvestigationalNaftopidil has been investigated for the treatment of Disorder of Urinary Stent.
MK-0557
go.drugbank.com/drugs/DB12168InvestigationalMK0557 has been investigated for the treatment of Schizophrenia and Paranoid Schizophrenia.